# Willowcroft Pharm Inc — Form D

Willowcroft Pharm Inc of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-25. The offering totals $5.0M. Industry: Pharmaceuticals.

## Offering

- Filed: 2014-04-25
- Form: D
- Accession: 0001605460-14-000002
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $5.0M
- Remaining: $5.0M
- Minimum investment: $50K
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-216281

## Issuer

- Name: Willowcroft Pharm Inc
- CIK: 0001605460
- Entity type: Corporation
- Jurisdiction: COLORADO
- Incorporated: 2009
- Address: 820 GRAPE STREET, DENVER, CO, 80220
- Phone: 303-875-7402

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Charles Foster Owen | Executive Officer | Denver, CO |

## More

- [CIK 1605460 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1605460&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001605460-14-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.